Pharmacokinetics and clinical effect during continuous epidural infusion with ropivacaine 2.5 mg/ml or bupivacaine 2.5 mg/ml for labour pain relief

Acta Anaesthesiologica Scandinavica

Volumn 42, Issue 8, 1998, Pages 890-896

  Irestedt, L ^a   Ekblom, A ^b   Olofsson, C ^a   Dahlstrom A C ^a   Emanuelsson, B M ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Bupivacaine; Continuous epidural analgesia; Labor pain relief; Neonatal evaluation; Pharmacokinetics; Ropivacaine

Indexed keywords

BUPIVACAINE; ROPIVACAINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DISPOSITION; EPIDURAL ANESTHESIA; EPIDURAL DRUG ADMINISTRATION; FEMALE; HUMAN; LABOR; NERVE BLOCK; OBSTETRIC ANALGESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031671605     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1998.tb05347.x     Document Type: Article

References (25)

1. Zaric D, Axelsson K, Guilbaud O, Seiander D. Sensory/motor separation with ropivacaine: an advantage in epidural pain management (abstract). In: The International Monitor. 16th Annual ESRA Congress, 1997.
2. Zaric D, Nydahl P, Philipson L, Samuelsson L, Heierson A, Axelsson K. The effect of continuous lumbar epidural infusion of ropivacaine (0.1%, 0.2% and 0.3%) and 0.25% bupivacaine on sensory and motor blockade in volunteers: a double-blind study. Reg Anesth 1996: 21: 14-25.
3. Albright, GA. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine. Anesthesiology 1979: 51: 285-287.
4. Arthur GR, Feldman HS, Covino BG. Comparative pharmacokinetics of bupivacaine and ropivacaine, a new amide local anesthetic. Anesth Analg 1988: 67: 1053-1058.
5. Lee A, Fagan D, Lamont M, Tucker GT, Halldin M, Scott DB. Disposition kinetics of ropivacaine in humans. Anesth Analg 1989: 69: 736-738.
6. Cummings AJ. A survey of pharmacokinetic data from pregnant women. Clin Pharmacokinet 1983: 25: 344-354.
7. Gin T. Pharmacokinetic optimisation of general anaesthesia in pregnancy. Clin Pharmacokinet 1993: 25: 59-70.
8. Perucca E. Drug metabolism in pregnancy, infancy and childhood. Pharmacol Ther 1987: 34: 129-143.
9. Santos AC, Pedersen H, Sallusto JA, Johnson HV, Morishima HO, Finster M et al. Pharmacokinetics of ropivacaine in non-pregnant and pregnant ewes. Anesth Analg 1990: 70: 262-266.
10. Huskisson EC. Measurement of pain. Lancet 1974: 2 (7889): 1127-1131.
11. Amiel-Tison C, Barrier G, Shnider SM, Levinson G, Hughes SC, Stefani SJ. A new neurologic and adaptive capacity scoring system for evaluating obstetric medications in full-term newborns. Anesthesiology 1982: 56: 340-350.
12. Björk M, Pettersson KJ, Österlöf G. Capillary gas chromatographic method for the simultaneous determination of local anaesthetics in plasma samples. J Chroniatogr 1990: 553: 229-234.
13. Arvidsson T, Eklund E. Determination of free concentration of ropivacaine and bupivacaine in blood plasma by ultrafiltration and coupled-column liquid chromatography. J Chroniatogr B 1995: 668: 91-98.
14. Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965: 2: 235-254.
15. Vertommen JD, Vandermeulen E, van Aken H, Vaes L, Soetens M, van Steenberge A et al. The effects of the addition of sufentanil to 0.125% bupivacaine on the quality of analgesia during labor and the incidence of instrumental deliveries. Aneshesiology 1991: 74: 809-814.
16. Miller AC. The effects of epidural analgesia on uterine activity and labor. International Journal of Obstetric Anesthesia 1997: 6: 2-18.
17. Olofsson Ch, Ekblom A, Ekman-Ordeberg G, Irestedt L. Obstetric outcome following epidural analgesia with bupivacaine-adrenaline 0.25% or bupivacaine 0.125% with sufentanil - a prospective randomized controlled study in 1000 parturients. Acta Anaesthesiol Scand 1998: 42: 284-292.
18. Morrison LMM, Emanuelsson B-M, McClure JH, Pollok AJ, McKeown DW, Brockway M et al. Efficacy and kinetics of extradural ropivacaine: comparison with bupivacaine, Br J Anaesth 1994: 72: 164-169.
19. Kopacz DJ, Emanuelsson B-M, Thompson GE, Carpenter RL, Stephenson CA. Pharmacokinetics of ropivacaine and bupivacaine for bilateral intercostal blockade in healthy male volunteers. Anesthesiology 1994: 81: 1139-1148.
20. Datta S, Camann W, Bader A, VanderBurgh L. Clinical effects and maternal and fetal plasma concentrations of epidural ropivacaine versus bupivacaine for cesarean section. Anesthesiology 1995: 82: 1346-1352.
21. Knudsen K, Beckman Suurküla M, Blomberg S, Sjövall J, Edvardsson N. Central nervous and cardiovascular effects during i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth 1997: 78: 507-514.
22. DiFazio CA. Metabolism of local anaesthetics in the fetus, newborn and adult. Br J Anaesth 1979: 51 (suppl): 29-34.
23. Albright GA. Local anesthetics. In: Albright GA, Ferguson JE, Joyce TH, Stevenson DK, eds. Anesthesia in obstetrics, maternal, fetal and neonatal aspects, 2nd edn. Woburn, MA: Butterworth 1986: 115-150.
24. Notarianni LJ. Plasma protein binding of drugs in pregnancy and neonates. Clin Pharmacokinet 1990: 18: 20-36.
25. Irestedt L, Emanuelsson B-M, Ekblom A, Olofsson C, Reventlid H. Ropivacaine 7.5 mg/ml for elective Caesarean section. A clinical and pharmacokinetic comparison of 150 mg and 187.5 mg. Acta Anaesthsiol Scand 1997: 41: 1149-1156.